Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TPP Matches Chinese Pharma & Capital With Western Assets

Executive Summary

Finding the right partner to enter the Chinese pharma market or access Chinese capital is not a trivial exercise for Western companies. Speaking at the 2018 Biotech Showcase, Tony Chu, founder and managing partner of TPP Healthcare, told Scrip that the advisory company was established to help Western companies achieve their Chinese goals. The sweet spot is late-stage assets for joint venturing or cash thirsty biotechs with programs focused on Asia Pacific health challenges.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC100532

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel